본문 바로가기 주메뉴 바로가기

제품소개

제품상세페이지

Proteogenix

[Proteogenix] SARS-CoV-2 RBD of Spike protein–JN.1

Cat-No. PX-COV-P084


Proteogenix는 Primary Antibody Biosimilar - Research Grade 

제품을 전문적으로 생산하는 20년의 경험이 있는 High Quality 제조사입니다.




제품 설명 


SARS-CoV-2 RBD of Spike protein–JN.1

 



제품 번호

 

PX-COV-P084

 



제품 특징


Product nameSARS-CoV-2 RBD of Spike protein–JN.1
Expression systemEukaryotic expression
Molecular weight27.68 kDa
Purity estimated>90% by SDS-PAGE
BufferPBS pH 7.4, 1mM EDTA, 4% Trehalose, 1% Mannitol
FormLiquid
Delivery conditionDry Ice
Storage condition4°C for short term; -20°C or -80°C for long term
BrandProteoGenix
Host speciesMammalian cells
Fragment TypeArg316-Lys533 (I332V, G339H, K356T, S371F, S373P, S375F, T376A, R403K, D405N, R408S, K417N, N440K, V445H, G446S, N450D, L452W, L455S, N460K, S477N, T478K, N481K, V482del, E484K, F486P, Q498R, N501Y, Y505H)
Aliases /SynonymsReceptor-Binding Domain, RBD, C_AAF77681.1
ReferencePX-COV-P084
NoteFor research use only. Not suitable for human use.




Publications


Segato, I.; Mele, D.; Forlani, G.; Dalla Gasperina, D.; Mondelli, M.U.; Varchetta, S. T Cell Responses to BA.2.86 and JN.1 SARS-CoV-2 Variants in Elderly Subjects. Vaccines 2024, 12, 1451. https://doi.org/10.3390/vaccines12121451




ProteoGenix의 모든 제품들을 만나보세요!

 

Proteogenix - Exclusive Distributor in South Korea "Morebio" 한국 독점 대리점 "모아바이오"